These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. Smak Gregoor PJ; de Sévaux RG; Ligtenberg G; Hoitsma AJ; Hené RJ; Weimar W; Hilbrands LB; van Gelder T J Am Soc Nephrol; 2002 May; 13(5):1365-73. PubMed ID: 11961025 [TBL] [Abstract][Full Text] [Related]
28. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question. Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340 [TBL] [Abstract][Full Text] [Related]
29. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515 [TBL] [Abstract][Full Text] [Related]
30. Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Padbury RT; Gunson BK; Dousset B; Hubscher SG; Buckels JA; Neuberger JM; Elias E; McMaster P Transplantation; 1993 Apr; 55(4):789-94. PubMed ID: 8475553 [TBL] [Abstract][Full Text] [Related]
31. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
32. Withdrawal of steroids from triple-drug therapy in kidney transplant patients. Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S Nephrol Dial Transplant; 2000 Jul; 15(7):1041-5. PubMed ID: 10862645 [TBL] [Abstract][Full Text] [Related]
33. Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine. Pelletier RP; Akin B; Ferguson RM Clin Transplant; 2006; 20(1):10-8. PubMed ID: 16556147 [TBL] [Abstract][Full Text] [Related]
34. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. van Gelder T; Hilbrands LB; Vanrenterghem Y; Weimar W; de Fijter JW; Squifflet JP; Hené RJ; Verpooten GA; Navarro MT; Hale MD; Nicholls AJ Transplantation; 1999 Jul; 68(2):261-6. PubMed ID: 10440399 [TBL] [Abstract][Full Text] [Related]
35. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil. Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B Transplantation; 2009 Mar; 87(6):934-41. PubMed ID: 19300199 [TBL] [Abstract][Full Text] [Related]
37. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Schulak JA; Mayes JT; Moritz CE; Hricik DE Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003 [TBL] [Abstract][Full Text] [Related]
39. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity. Klaus G; Jeck N; Konrad M; Förster B; Soergel M Clin Nephrol; 2001 Dec; 56(6):S37-42. PubMed ID: 11770812 [TBL] [Abstract][Full Text] [Related]
40. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up. Lee YJ; Kim B; Lee JE; Kim YG; Kim DJ; Kim SJ; Joh JW; Oh HY; Huh W Transpl Int; 2010 Feb; 23(2):147-54. PubMed ID: 19744223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]